by Jason Kroh | Aug 13, 2025 | Blog - Clinical Trial Focus, Blog - Healthcare Focus
The advent of wearable technology is changing how we monitor health across a range of conditions, offering continuous, real-world insights into patients’ vitals and physiological data. At Strados Labs, our goal was to develop a wearable specifically for monitoring...
by Tom deLaubenfels, PhD | Jun 17, 2025 | Blog - Clinical Trial Focus
Cough monitoring, namely for the measurement of cough frequency, has seen increased interest and use in clinical trials to provide a greater understanding of treatment effects on subjects’ cough. As sponsors and researchers evaluate cough monitoring technologies for...
by Strados Labs | Jun 3, 2025 | Blog - Clinical Trial Focus
At this year’s ATS conference, Strados Labs was proud to host the session, “Tuning In To Cough in Pulmonary Fibrosis: How Should We Address the Gap?” presented by Dr. Toby Maher, Professor of Clinical Medicine at the Keck School of Medicine, USC. The talk focused on...
by Strados Labs | Mar 11, 2025 | Blog - Clinical Trial Focus
Cough monitoring has emerged as an increasingly common practice in research studies and drug development in recent years to objectively measure changes in subjects’ cough. As drug developers consider including cough frequency as an endpoint in their studies,...
by Richard Powers | Jan 30, 2025 | Blog - Clinical Trial Focus
In research studies and healthcare settings, minimizing patient burden is essential for reliable data collection with wearables and devices. At Strados Labs, we understand the importance of these factors with the RESP® Biosensor, which is designed to continuously...
by Yu Kan Au, MD | Dec 4, 2024 | Blog - Clinical Trial Focus
Increased importance has been placed in recent years on the ability of idiopathic pulmonary fibrosis (IPF) treatments to impact how patients feel and function, beyond survival (Raghu, et al., 2024). In IPF, one of the most burdensome symptoms impacting how patients...
